Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
23 participants
OBSERVATIONAL
2009-01-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Skane University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Departments of Medicine, Malmö University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanna Hlebowicz, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Skane University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Departments of Medicine, Malmö University Hospital
Malmo, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dencker M, Bjorgell O, Hlebowicz J. Effect of food intake on 92 oncological biomarkers by the Proseek Oncology II panel. BMC Res Notes. 2019 Apr 2;12(1):199. doi: 10.1186/s13104-019-4237-9.
Hlebowicz J, Lindstedt S, Bjorgell O, Dencker M. The effect of endogenously released glucose, insulin, glucagon-like peptide 1, ghrelin on cardiac output, heart rate, stroke volume, and blood pressure. Cardiovasc Ultrasound. 2011 Dec 29;9:43. doi: 10.1186/1476-7120-9-43.
Hlebowicz J, Lindstedt S, Bjorgell O, Dencker M. Relationship between postprandial changes in cardiac left ventricular function, glucose and insulin concentrations, gastric emptying, and satiety in healthy subjects. Nutr J. 2011 Mar 23;10:26. doi: 10.1186/1475-2891-10-26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
353/2008b
Identifier Type: -
Identifier Source: org_study_id